News and Events


Yusuf Abul-Hajj

Yusuf Abul-Hajj has been named an American Chemical Society (ACS) Fellow. He will be recognized at the society’s fall national meeting in Boston in August.

Dr. Abul-Hajj was recognized for his groundbreaking research in steroid carcinogenesis, identifying aromatase as playing a key role in breast cancer, detailing how Aromatase Inhibitors work on breast cancer, disseminating medicinal chemistry research as the Senior Editor of the Journal of Medicinal Chemistry, and as a symposium organizer at several ACS national meetings.